Premium
Pegylated interferon and ribavirin: a therapeutic option in patients who fail to respond to telaprevir‐based triple therapy?
Author(s) -
Dai ChiaYen,
Chuang WanLong,
Yu MingLung
Publication year - 2013
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.26434
Subject(s) - telaprevir , ribavirin , medicine , pegylated interferon , gastroenterology , combination therapy , cirrhosis , discontinuation , peginterferon alfa 2a , hepatitis c virus , immunology , virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom